Quantcast

Latest autoimmune diseases Stories

2014-06-05 16:27:14

SAN FRANCISCO, BOSTON and HAMILTON, Ontario, June 5, 2014 /PRNewswire-USNewswire/ -- Some of North America's leading scleroderma advocacy and research organizations today announced they are joining forces during June's Scleroderma Awareness Month, with a social media campaign to compel more people to learn more about the little-known and often misunderstood disease. http://photos.prnewswire.com/prnvar/20140605/94801 The primary partners are Scleroderma Foundation, Scleroderma...

2014-06-05 12:27:11

CHERRY HILL, N.J., June 5, 2014 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to announce that the newly published About MS booklet is now available as both a printed and online publication. MSAA's About MS: An Overview of Multiple Sclerosis (MS), Including Symptoms, Treatments, and Research offers an overview of multiple sclerosis including history, process and symptoms, types of MS, possible causes, diagnosing and evaluating disease activity,...

2014-06-03 23:02:18

Signature event funds research, programs, support and breakthrough initiatives Toronto, Ont. (PRWEB) June 03, 2014 This Sunday, June 8th marks the single biggest day for arthritis fundraising in Canada. The 5th annual Walk to Fight Arthritis unfolds in over 25 communities coast-to-coast, raising funds and awareness for the country’s leading chronic condition. The Walk unites families, friends and organizations in a common goal of delivering support and solutions for the over 4.6 million...

2014-06-03 12:38:56

Company sponsors Walk to End Lupus Now(TM) events and employees show support for people with the disease during Lupus Awareness Month HAYWARD, Calif., June 3, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced its sponsorship of the Lupus Foundation of America's (LFA) eight national office Walk to End Lupus Now(TM) events and its support of a variety of Lupus Awareness Month activities. Questcor supported numerous lupus awareness, education and...

2014-06-03 08:32:05

SAN DIEGO, June 3, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the initiation of dosing in an investigational Phase 1b clinical trial of APD334, a novel, oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P(1)) receptor, to evaluate the compound for the treatment of a number of autoimmune diseases. This randomized, double-blind and placebo-controlled Phase 1b trial will evaluate the safety, tolerability and pharmacokinetics...

2014-05-29 23:19:59

The 2014 LDN at the MEET is being organised by the charity the LDN Research Trust in the UK and Mark’s Dugs in the US. The conference reviews, compares and contrasts the most recent data and treatments for a variety of Auto-Immune and Immuno-modulated Conditions. (PRWEB) May 29, 2014 International conference to raise awareness about a ground-breaking drug. Physicians, patients and experts from all over the world will gather in Las Vegas this November at a major conference to discuss and...

2014-05-29 16:26:50

Snap a "Selfie" and Become a Part of Our Next Awareness Campaign DANVERS, Mass., May 29, 2014 /PRNewswire-USNewswire/ -- Too many people in the United States know nothing about scleroderma, a mysterious and frequently disabling condition, which affects an estimated 300,000 people, so this June the Scleroderma Foundation wants to increase awareness of the disease that can strip away a person's independence and quality of life. Scleroderma strikes women 4-to-1 over men, with the onset...

2014-05-29 16:26:10

VANCOUVER, May 29, 2014 /PRNewswire/ - Augurex Life Sciences Corp. announces a ground-breaking body of new data that will publish during the European League Against Rheumatism (EULAR) Annual Congress of Rheumatology taking place June 11-14 in Paris. Investigators will present the studies listed in the schedule below, which to date along with other publications, represent over 2000 patients evaluated with the 14-3-3 eta blood test. This follows the very recent publication of a study...

2014-05-29 08:29:17

RALEIGH, N.C., May 29, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the diagnosis and treatment of metabolic disease, announced today the appointment of Steven Delmar, CPA, as Chief Financial Officer. Mr. Delmar brings more than 35 years of financial and operational executive leadership experience to the company, serving most recently as Director of Business Operations at Computer Sciences Corporation (CSC)....

2014-05-28 16:27:04

ROME, May 28, 2014 /PRNewswire/ -- Sigma-Tau announces that Synacthen (R) (tetracosactide hexa-acetate salt) is now available again in most of the European countries. (Logo: http://photos.prnewswire.com/prnh/20140528/689733 ) Manufacturing challenges connected to tetracosactide over the past months caused the shortage of -Synacthen(R)- for patients throughout Europe and Sigma-Tau has devoted all its efforts in reestablishing the supply chain into these...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.